"The increase in sales of generic medicines is fine. The fact remains that the new law which provides for the obligation to prescribe the active ingredient in a prescription still creates too much confusion. Some patients see their medicine changed from time to time, so much so that get to interrupt the therapy waiting to clarify with your doctor.In my opinion, the solution is one: remove the replaceability.
Doctors should be able to write the name of the generic in the prescription". This is what the national general secretary of Fimmg (Italian Federation of general practitioners) affirms, commenting on the Assogenerici data.
May 30, 2013 – PharmaKronos
Lorenzin, more generic equals closer to the EU
"It is a positive factor that brings us closer to Europe, we are rebalancing the system". This is the comment of the Minister of Health Beatrice Lorenzin, on the sidelines of her speech at the Forum Pa in Rome, on the Assogenerici data. According to the former head of the ministry and proponent of the law, Renato Balduzzi, it "starts to work, without creating havoc in the system. It is useful for citizens, patients and the system as a whole. This increase - adds the former minister – goes in the direction of a gradual realignment of Italy with respect to the other European countries", on the consumption of generic medicines. "This was the wish of the legislator", concludes Balduzzi.
May 30, 2013 – PharmaKronos
Fedenziani, no to generics from pharmacists. Fofi, unfounded sentences
«Yes to generics as long as they are prescribed by general practitioners, and not by pharmacists». To accuse the category is Roberto Messina, president of Federanziani in a press release, underlining that «the choice of which box to deliver to the patient should not be left to a third party such as the pharmacist, exposing him to the risk of mistrust towards the substance
